Schematic diagram illustrating some of the major abnormalities related to sensitized D1R-signaling and associated to LID
Schematic diagram illustrating some of the major abnormalities related to sensitized D1R-signaling and associated to LID. In PD, the loss of striatal dopamine leads to sensitization of D1Rs on the striatonigral MSNs of the direct pathway. Emerging evidence indicates that, if persistent, this phenomenon results in the appearance of dyskinesia. D1R sensitization may be caused by augmented D1R expression at the cell surface. Chronic administration of l-DOPA promotes the release of BDNF from corticostriatal neurons, leading to activation of TrκB receptors and increased expression of D3Rs, specifically in striatonigral MSNs. Direct interaction with D3Rs is likely to increase the levels of membrane-bound D1Rs, thereby exacerbating D1R sensitization and dyskinetic behavior. In line with this possibility, D3R antagonists have been found to counteract LID in experimental models of PD. Sensitized D1R transmission may also be caused by increased levels of adenylyl cyclase 5 (AC 5) in striatonigral MSNs. Increased responsiveness of the D1R/Gαolf/AC5 machinery to l-DOPA results in augmented synthesis of cAMP and hyper-activation of PKA and DARPP-32. Pharmacological inhibition of PKA, or genetic inactivation of DARPP-32 have been shown to reduce LID. Abnormal PKA/DARPP-32 signaling increases the phosphorylation of GluR1. This effect promotes the excitability of MSNs and may participate in the loss of corticostriatal LTD and depotentiation associated to LID. Sensitized D1R-mediated transmission leads also to activation of ERK, which controls transcriptional and translational processes. Both pharmacological and genetic suppression of ERK signaling counteracts the development and expression of LID. In the nucleus, PKA/DARPP-32 and ERK/MSK1 signaling leads to phosphorylation of CREB and histone H3, and increased expression of immediate early genes and prodynorphin. Reduced expression/activity of ΔfosB efficiently counteracts LID. Activation of ERK promotes mTORC1-dependent signaling, thereby accelerating mRNA translation. Blockade of mTORC1 with rapamycin has been found to attenuate the development of LID. Red color indicates receptors or signaling components whose targeting reduces LID. See text for abbreviations.
Publication
L-DOPA-Induced Dyskinesia and Abnormal Signaling in Striatal Medium Spiny Neurons: Focus on Dopamine D1 Receptor-Mediated Transmission. (2011) Michael Feyder, et al. Front Behav Neurosci. 2011;5:71. Figure: F1.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | BDNF | BDNF | ncbigene_symbol | BDNF | 627 |
| Homo sapiens | Primates | BDNF | BDNF | ncbigene_synonym | BDNF-AS | 497258 |
| Homo sapiens | Primates | DIR | DIR | ncbigene_synonym | AVPR2 | 554 |
| Homo sapiens | Primates | AC | ADCY | famplex_relations | ADCY1 | 107 |
| Homo sapiens | Primates | AC | ADCY | famplex_relations | ADCY2 | 108 |
| Homo sapiens | Primates | AC | ADCY | famplex_relations | ADCY3 | 109 |
| Homo sapiens | Primates | AC | ADCY | famplex_relations | ADCY4 | 196883 |
| Homo sapiens | Primates | AC | ADCY | famplex_relations | ADCY5 | 111 |
| Homo sapiens | Primates | AC | ADCY | famplex_relations | ADCY6 | 112 |
| Homo sapiens | Primates | AC | ADCY | famplex_relations | ADCY7 | 113 |
| Homo sapiens | Primates | AC | ADCY | famplex_relations | ADCY8 | 114 |
| Homo sapiens | Primates | AC | ADCY | famplex_relations | ADCY9 | 115 |
| Homo sapiens | Primates | AC | ADCY | famplex_relations | ADCY10 | 55811 |
| Homo sapiens | Primates | TrkB | TRKB | ncbigene_synonym | NTRK2 | 4915 |
| Homo sapiens | Primates | ATP | ATP | ncbigene_synonym | ATP8A2 | 51761 |
| Homo sapiens | Primates | DARPP-32 | DARPP-32 | ncbigene_synonym | PPP1R1B | 84152 |
| Homo sapiens | Primates | PKA/DARPP-32– | PKA | famplex_relations | PRKAR1A | 5573 |
| Homo sapiens | Primates | PKA/DARPP-32– | PKA | famplex_relations | PRKAR1B | 5575 |
| Homo sapiens | Primates | PKA/DARPP-32– | PKA | famplex_relations | PRKAR2A | 5576 |
| Homo sapiens | Primates | PKA/DARPP-32– | PKA | famplex_relations | PRKAR2B | 5577 |
| Homo sapiens | Primates | PKA/DARPP-32– | PKA | famplex_relations | PRKACA | 5566 |
| Homo sapiens | Primates | PKA/DARPP-32– | PKA | famplex_relations | PRKACB | 5567 |
| Homo sapiens | Primates | PKA/DARPP-32– | PKA | famplex_relations | PRKACG | 5568 |
| Homo sapiens | Primates | P-ERK | ERK | ncbigene_synonym | EPHB2 | 2048 |
| Homo sapiens | Primates | P-ERK | ERK | ncbigene_synonym | MAPK1 | 5594 |
| Homo sapiens | Primates | P-ERK | ERK | famplex_relations | MAPK3 | 5595 |
| Homo sapiens | Primates | MTORC1 | MTORC1 | famplex_relations | MTOR | 2475 |
| Homo sapiens | Primates | MTORC1 | MTORC1 | famplex_relations | RPTOR | 57521 |
| Homo sapiens | Primates | P-MSK1 | MSK1 | ncbigene_synonym | RPS6KA5 | 9252 |
| Homo sapiens | Primates | PDyn | PDYN | ncbigene_symbol | PDYN | 5173 |
| Homo sapiens | Primates | zif268 | ZIF268 | ncbigene_synonym | EGR1 | 1958 |
| Homo sapiens | Primates | P-CREB | CREB | ncbigene_synonym | CREB1 | 1385 |
| Homo sapiens | Primates | P-CREB | CREB | famplex_relations | CREB3 | 10488 |
| Homo sapiens | Primates | P-CREB | CREB | famplex_relations | CREB5 | 9586 |
| Homo sapiens | Primates | P-CREB | CREB | famplex_relations | CREB3L1 | 90993 |
| Homo sapiens | Primates | P-CREB | CREB | famplex_relations | CREB3L2 | 64764 |
| Homo sapiens | Primates | P-CREB | CREB | famplex_relations | CREB3L3 | 84699 |
| Homo sapiens | Primates | P-CREB | CREB | famplex_relations | CREB3L4 | 148327 |
| Homo sapiens | Primates | P-CREB | CREB | famplex_relations | CREM | 1390 |
| Homo sapiens | Primates | P-CREB | CREB | famplex_relations | ATF1 | 466 |
| Homo sapiens | Primates | P-CREB | CREB | famplex_relations | ATF2 | 1386 |
| Homo sapiens | Primates | c-fos | C-FOS | ncbigene_synonym | FOS | 2353 |
| Homo sapiens | Primates | arc | ARC | ncbigene_symbol | ARC | 23237 |
| Homo sapiens | Primates | arc | ARC | ncbigene_synonym | NOL3 | 8996 |
| Homo sapiens | Primates | GluR1 | GLUR1 | ncbigene_synonym | GRIA1 | 2890 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| L-DOPA | Levodopa | mesh:D007980 | L-dopa | chebi:15765 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|